Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours

British Journal of Cancer

Volumn 95, Issue 4, 2006, Pages 541-547

  Satoh, Y ^a,b   Nakadate, H ^c   Nakagawachi, T ^a,b   Higashimoto, K ^a   Joh, K ^a   Masaki, Z ^b   Uozumi, J ^b   Kaneko, Y ^d   Mukai, T ^a   Soejima, H ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY HOSPITAL   (Japan)

^d SAITAMA CANCER CENTER   (Japan)

Author keywords

DNA methylation; Epigenetics; Genetics; Loss of heterozygosity; Loss of imprinting; Wilms' tumour

Indexed keywords

CATALASE; GENOMIC DNA; PROTEIN P57; RNA; SOMATOMEDIN B; TRANSCRIPTION FACTOR PAX6;

ARTICLE; CHROMOSOME 11P; CONTROLLED STUDY; CTNNBI GENE; DELETION MUTANT; DNA METHYLATION; EPIGENETICS; FETUS; GENE; GENE LOCUS; GENETIC ANALYSIS; GENOME IMPRINTING; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; NEPHROBLASTOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; WT1 GENE;

BETA CATENIN; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN-DEPENDENT KINASE INHIBITOR P57; EPIGENESIS, GENETIC; GENES, WILMS TUMOR; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MUTATION; PROTEINS; WILMS TUMOR;

EID: 33747201884     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603302     Document Type: Article

References (39)

1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520
2. Chung WY, Yuan L, Feng L, Hensle T, Tycko B (1996) Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Mol Genet 5: 1101-1108
3. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP (2002) Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70: 604-611
4. Dome JS, Coppes MJ (2002) Recent advances in Wilms tumor genetics. Curr Opin Pediatr 14: 5-11
5. Ehrlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, Chintagumpala M, Champagne M, Parham D, Liang G, Malik K, Laird PW (2002) Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 21: 6694-6702
6. Englert C (1998) WT1 - more than a transcription factor? Trends Biochem Sci 23: 389-393
7. Feinberg AP (2000) The two-domain hypothesis in Beckwith-Wiedemann syndrome. J Clin Invest 106: 739-740
8. Fukuzawa R, Breslow NE, Morison IM, Dwyer P, Kusafuka T, Kobayashi Y, Becroft DM, Beckwith JB, Perlman EJ, Reeve AE (2004) Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet 363: 446-451
9. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778
10. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF (2002) Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 21: 4345-4349
11. KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5: 783-788
12. Huff V (1998) Wilms tumor genetics. Am J Med Genet 79: 260-267
13. Kaneko Y, Egues MC, Rowley JD (1981) Interstitial deletion of short arm of chromosome 11 limited to Wilms' tumor cells in a patient without aniridia. Cancer Res 41: 4577-4578
14. KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene 21: 2741-2749
15. Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, Mori N, Saito H, Kinoshita T (2002) DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 100: 2572-2577
16. Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60: 6288-6292
17. Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF (1992) RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J Natl Cancer Inst 84: 181-187
18. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W, Tycko B (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 7: 440-447
19. Nakadate H, Tsuchiya T, Maseki N, Hatae Y, Tsunematsu Y, Horikoshi Y, Ishida Y, Kikuta A, Eguchi H, Endo M, Miyake M, Sakurai M, Kaneko Y (1999) Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor. Genes Chromosomes Cancer 25: 26-32
20. Nakadate H, Yokomori K, Watanabe N, Tsuchiya T, Namiki T, Kobayshi H, Suita S, Tsunematsu Y, Horikoshi Y, Hatae Y, Endo M, Komada Y, Eguchi H, Toyoda Y, Kikuta A, Kobayashi R, Kaneko Y (2001) Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan. Int J Cancer 94: 396-400
21. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362: 749-751
22. KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am J Hum Genet 61: 295-303
23. Okamoto K, Morison IM, Taniguchi T, Reeve AE (1997) Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc Natl Acad Sci USA 94: 5367-5371
24. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, vanHeyningen V, Hastie N (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197
25. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362: 747-749
26. Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317: 258-260
27. Reik W, Murrell A (2000) Genomic imprinting. Silence across the border. Nature 405: 408-409
28. Satoh Y, Nakagawachi T, Nakadate H, Kaneko Y, Masaki Z, Mukai T, Soejima H (2003) Significant reduction of WT1 gene expression possibly due to epigenetic alteration in Wilms' tumor. J Biochem (Tokyo) 133: 303-308
29. Shin JY, Kim HS, Park J, Park JB, Lee JY (2000) Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res 60: 262-265
30. Soejima H, McLay J, Hatada I, Mukai T, Jinno Y, Niikawa N, Yun K (1998) Comparative RT-PCR and in situ hybridization analyses of human imprinted p57KIP2 and IGF2 gene transcripts in fetal kidney and Wilms tumors using archival tissue. Lab Invest 78: 19-28
31. Soejima H, Nakagawachi T, Zhao W, Higashimoto K, Urano T, Matsukura S, Kitajima Y, Takeuchi M, Nakayama M, Oshimura M, Miyazaki K, Joh K, Mukai T (2004) Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene 23: 4380-4388
32. Soejima H, Yun K (1998) Allele specific-polymerase chain reaction: a novel method for investigation of the imprinted IGF2 gene. Lab Invest 78: 641-642
33. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet 7: 433-439
34. Taniguchi T, Okamoto K, Reeve AE (1997) Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Oncogene 14: 1201-1206
35. KIP2 in Wilms' tumor. Cancer Res 56: 5723-5727
36. Wagner KJ, Cooper WN, Grundy RG, Caldwell G, Jones C, Wadey RB, Morton D, Schofield PN, Reik W, Latif F, Maher ER (2002) Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer. Oncogene 21: 7277-7282
37. Watanabe N, Nakadate H, Haruta M, Sugawara W, Sasaki F, Tsunematsu Y, Kikuta A, Fukuzawa M, Okita H, Hata J, Soejima H, Kaneko Y (2006) Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor. Genes Chromosomes Cancer 45: 592-601
38. Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B (2005) Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Mol Cancer Res 3: 493-502
39. Yun K, Soejima H, Merrie AE, McCall JL, Reeve AE (1999) Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR. J Pathol 187: 518-522